{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:20:54Z","timestamp":1783772454322,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Science and Health Project of Hunan Provincial Natural Science Foundation in 2024","award":["2024JJ9505"],"award-info":[{"award-number":["2024JJ9505"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11626-025-01121-3","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:28:10Z","timestamp":1763479690000},"page":"1261-1272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MOF promotes cisplatin resistance in lung cancer cells by enhancing WSTF acetylation"],"prefix":"10.1007","volume":"61","author":[{"given":"Qian","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"crossref","unstructured":"Ashrafi A, Akter Z, Modareszadeh P, Modareszadeh P, Berisha E, Alemi PS, Chacon Castro MDC, Deese AR, Zhang L (2022) Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance. Cancers (Basel) 14(19):4562","DOI":"10.3390\/cancers14194562"},{"issue":"3","key":"1121_CR2","first-page":"242","volume":"19","author":"IV Baro\u0161","year":"2019","unstructured":"Baro\u0161 IV, Tanaskovi\u0107 N, Pellas U, Eri \u017d, Tadi\u0107 Latinovi\u0107 L, Tot T (2019) Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients. Bosn J Basic Med Sci 19(3):242\u2013248","journal-title":"Bosn J Basic Med Sci"},{"issue":"3","key":"1121_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"750","key":"1121_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3399\/bjgp25X740493","volume":"75","author":"SH Bradley","year":"2025","unstructured":"Bradley SH, Baldwin D, Bhartia BSK, Black GB, Callister ME, Clayton K, Eccles SR, Evison M, Fox J, Hamilton W et al (2025) Achieving earlier diagnosis of symptomatic lung cancer. Br J Gen Pract 75(750):40\u201343","journal-title":"Br J Gen Pract"},{"issue":"1","key":"1121_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41420-023-01478-y","volume":"9","author":"M Cai","year":"2023","unstructured":"Cai M, Xu S, Jin Y, Yu J, Dai S, Shi XJ, Guo R (2023) HMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2. Cell Death Discov 9(1):179","journal-title":"Cell Death Discov"},{"issue":"8","key":"1121_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04033-8","volume":"12","author":"KB Chen","year":"2021","unstructured":"Chen KB, Yang W, Xuan Y, Lin AJ (2021) Mir-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1. Cell Death Dis 12(8):748","journal-title":"Cell Death Dis"},{"issue":"5942","key":"1121_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942):834\u2013840","journal-title":"Science"},{"issue":"41","key":"1121_CR8","doi-asserted-by":"publisher","first-page":"11507","DOI":"10.1073\/pnas.1614430113","volume":"113","author":"J Hu","year":"2016","unstructured":"Hu J, Lieb JD, Sancar A, Adar S (2016) Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution. Proc Natl Acad Sci U S A 113(41):11507\u201311512","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1121_CR9","doi-asserted-by":"crossref","unstructured":"Hu M, He F, Thompson EW, Ostrikov KK, Dai X (2022) Lysine acetylation, cancer hallmarks and emerging onco-therapeutic opportunities. Cancers (Basel) 14(2)","DOI":"10.3390\/cancers14020346"},{"issue":"1","key":"1121_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-021-00408-5","volume":"14","author":"NN Jeffery","year":"2021","unstructured":"Jeffery NN, Davidson C, Peslak SA, Kingsley PD, Nakamura Y, Palis J, Bulger M (2021) Histone H2A.X phosphorylation and caspase-initiated chromatin condensation in late-stage erythropoiesis. Epigenetics Chromatin 14(1):37","journal-title":"Epigenetics Chromatin"},{"issue":"12","key":"1121_CR11","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1093\/nar\/gkz309","volume":"47","author":"JH Ji","year":"2019","unstructured":"Ji JH, Min S, Chae S, Ha GH, Kim Y, Park YJ, Lee CW, Cho H (2019) De novo phosphorylation of H2AX by WSTF regulates transcription-coupled homologous recombination repair. Nucleic Acids Res 47(12):6299\u20136314","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1121_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12964-022-00870-y","volume":"20","author":"F Kong","year":"2022","unstructured":"Kong F, Ma L, Wang X, You H, Zheng K, Tang R (2022) Regulation of epithelial-mesenchymal transition by protein lysine acetylation. Cell Commun Signal 20(1):57","journal-title":"Cell Commun Signal"},{"issue":"4","key":"1121_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/cpr.12177","volume":"48","author":"Q Li","year":"2015","unstructured":"Li Q, Sun H, Shu Y, Zou X, Zhao Y, Ge C (2015) hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2). Cell Prolif 48(4):436\u2013442","journal-title":"Cell Prolif"},{"key":"1121_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.573502","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Shi B, Liu X, An HX (2020) Acetylation and deacetylation of DNA repair proteins in cancers. Front Oncol 10:573502","journal-title":"Front Oncol"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"8149","DOI":"10.2147\/OTT.S261799","volume":"13","author":"Z Lin","year":"2020","unstructured":"Lin Z, Pan J, Chen L, Wang X, Chen Y (2020) MiR-140 resensitizes Cisplatin-resistant NSCLC cells to Cisplatin treatment through the SIRT1\/ROS\/JNK pathway. Onco Targets Ther 13:8149\u20138160","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1121_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/ol.2013.1380","volume":"6","author":"N Liu","year":"2013","unstructured":"Liu N, Zhang R, Zhao X, Su J, Bian X, Ni J, Yue Y, Cai Y, Jin J (2013) A potential diagnostic marker for ovarian cancer: involvement of the histone acetyltransferase, human males absent on the first. Oncol Lett 6(2):393\u2013400","journal-title":"Oncol Lett"},{"issue":"27","key":"1121_CR17","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1038\/s41388-020-1350-0","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang YY, Wang SQ, Li M, Long YH, Li YF, Liu YK, Li YH, Wang YQ, Mi JS et al (2020) WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. Oncogene 39(27):5056\u20135067","journal-title":"Oncogene"},{"key":"1121_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.taap.2018.07.007","volume":"355","author":"MW Luczak","year":"2018","unstructured":"Luczak MW, Zhitkovich A (2018) Monoubiquitinated \u03b3-H2AX: abundant product and specific biomarker for non-apoptotic DNA double-strand breaks. Toxicol Appl Pharmacol 355:238\u2013246","journal-title":"Toxicol Appl Pharmacol"},{"key":"1121_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jsbmb.2017.06.003","volume":"177","author":"J Lundqvist","year":"2018","unstructured":"Lundqvist J, Kirkegaard T, Laenkholm AV, Duun-Henriksen AK, Bak M, Feldman D, Lykkesfeldt AE (2018) Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1\u03b1,25-dihydroxyvitamin D(3). J Steroid Biochem Mol Biol 177:171\u2013178","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"1121_CR20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.cellsig.2016.07.008","volume":"28","author":"J Meng","year":"2016","unstructured":"Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun Y, Liang XH, Wang JB, Mei QB, Zhang F et al (2016) WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K\/Akt and IL-6\/STAT3 signaling pathways. Cell Signal 28(11):1673\u20131682","journal-title":"Cell Signal"},{"issue":"5","key":"1121_CR21","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.stemcr.2017.10.002","volume":"9","author":"K Mujoo","year":"2017","unstructured":"Mujoo K, Pandita RK, Tiwari A, Charaka V, Chakraborty S, Singh DK, Hambarde S, Hittelman WN, Horikoshi N, Hunt CR et al (2017) Differentiation of human induced pluripotent or embryonic stem cells decreases the DNA damage repair by homologous recombination. Stem Cell Reports 9(5):1660\u20131674","journal-title":"Stem Cell Reports"},{"key":"1121_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115323","volume":"206","author":"AMP Romani","year":"2022","unstructured":"Romani AMP (2022) Cisplatin in cancer treatment. Biochem Pharmacol 206:115323","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 2","key":"1121_CR23","doi-asserted-by":"publisher","first-page":"ii56","DOI":"10.1093\/neuonc\/noab180.195","volume":"23","author":"KSS Sarnow","year":"2021","unstructured":"Sarnow KSS, Rio O, Mukherjee J, Bjerkvig R, Johannessen TA (2021) P15.02 loss of Williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression. Neuro Oncol 23(Suppl 2):ii56. https:\/\/doi.org\/10.1093\/neuonc\/noab180.195","journal-title":"Neuro Oncol"},{"key":"1121_CR24","doi-asserted-by":"crossref","unstructured":"Sharif SB, Zamani N, Chadwick BP (2021) BAZ1B the protean protein. Genes (Basel) 12(10):1541","DOI":"10.3390\/genes12101541"},{"key":"1121_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040675","author":"M Shiraiwa","year":"2022","unstructured":"Shiraiwa M, Kitakaze T, Yamashita Y, Ukawa Y, Mukai K, Ashida H (2022) Pectolinarigenin induces antioxidant enzymes through Nrf2\/ARE pathway in HepG2 cells. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11040675","journal-title":"Antioxidants"},{"issue":"1","key":"1121_CR26","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"key":"1121_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00232-20","author":"M Singh","year":"2020","unstructured":"Singh M, Bacolla A, Chaudhary S, Hunt CR, Pandita S, Chauhan R, Gupta A, Tainer JA, Pandita TK (2020) Histone acetyltransferase MOF orchestrates outcomes at the crossroad of oncogenesis, DNA damage response, proliferation, and stem cell development. Mol Cell Biol. https:\/\/doi.org\/10.1128\/MCB.00232-20","journal-title":"Mol Cell Biol"},{"issue":"9\u201310","key":"1121_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s10495-024-02008-6","volume":"29","author":"Y Song","year":"2024","unstructured":"Song Y, Wang L, Zheng Y, Jia L, Li C, Chao K, Li L, Sun S, Wei Y, Ge Y et al (2024) Deubiquitinating enzyme USP28 inhibitor AZ1 alone and in combination with cisplatin for the treatment of non-small cell lung cancer. Apoptosis 29(9\u201310):1793\u20131809","journal-title":"Apoptosis"},{"key":"1121_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119399","volume":"276","author":"Z Song","year":"2021","unstructured":"Song Z, Jia G, Ma P, Cang S (2021) Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6a modification-mediated ferroptosis. Life Sci 276:119399","journal-title":"Life Sci"},{"key":"1121_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010099","author":"J Su","year":"2016","unstructured":"Su J, Wang F, Cai Y, Jin J (2016) The functional analysis of histone acetyltransferase MOF in tumorigenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17010099","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1121_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30780","volume":"10","author":"T Sun","year":"2024","unstructured":"Sun T, Zhang P, Zhang Q, Wang B, Zhao Q, Liu F, Ma X, Zhao C, Zhou X, Chen R et al (2024) Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis. Heliyon 10(10):e30780","journal-title":"Heliyon"},{"issue":"1","key":"1121_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76683-5","volume":"14","author":"M Valceski","year":"2024","unstructured":"Valceski M, Engels E, Vogel S, Paino J, Potter D, Hollis C, Khochaiche A, Barnes M, Cameron M, O\u2019Keefe A et al (2024) A novel approach to double-strand DNA break analysis through \u03b3-H2AX confocal image quantification and bio-dosimetry. Sci Rep 14(1):27591","journal-title":"Sci Rep"},{"issue":"7","key":"1121_CR33","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1158\/0008-5472.CAN-16-2374","volume":"77","author":"DG Valerio","year":"2017","unstructured":"Valerio DG, Xu H, Chen CW, Hoshii T, Eisold ME, Delaney C, Cusan M, Deshpande AJ, Huang CH, Lujambio A et al (2017) Histone acetyltransferase activity of MOF is required for MLL-AF9 leukemogenesis. Cancer Res 77(7):1753\u20131762","journal-title":"Cancer Res"},{"key":"1121_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108719","author":"T Wu","year":"2023","unstructured":"Wu T, Zhao B, Cai C, Chen Y, Miao Y, Chu J, Sui Y, Li F, Chen W, Cai Y et al (2023) The males absent on the first (MOF) mediated acetylation alters the protein stability and transcriptional activity of YY1 in HCT116 cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24108719","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1121_CR35","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, Li H, Lu J, Wang H, Zhou Q (2023) NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in Bladder Cancer. Cancer Res 83(10):1666\u20131683","journal-title":"Cancer Res"},{"key":"1121_CR36","doi-asserted-by":"crossref","unstructured":"Yang L, Du C, Chen H, Diao Z (2021) Downregulation of Williams syndrome transcription factor (WSTF) suppresses glioblastoma cell growth and invasion by inhibiting PI3K\/AKT signal pathway. Eur J Histochem 65(4)","DOI":"10.4081\/ejh.2021.3255"},{"issue":"4","key":"1121_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/bph.13690","volume":"174","author":"WK Yu","year":"2017","unstructured":"Yu WK, Wang Z, Fong CC, Liu D, Yip TC, Au SK, Zhu G, Yang M (2017) Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-induced DNA damage. Br J Pharmacol 174(4):302\u2013313","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1121_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112939","volume":"42","author":"K Zhao","year":"2023","unstructured":"Zhao K, Zheng M, Su Z, Ghosh S, Zhang C, Zhong W, Ho JWK, Jin G, Zhou Z (2023) MOF-mediated acetylation of SIRT6 disrupts SIRT6-FOXA2 interaction and represses SIRT6 tumor-suppressive function by upregulating ZEB2 in NSCLC. Cell Rep 42(8):112939","journal-title":"Cell Rep"},{"issue":"2","key":"1121_CR39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/bab.2386","volume":"70","author":"F Zhou","year":"2023","unstructured":"Zhou F, Lu J, Jin W, Li Z, Xu D, Gu L (2023) The role of USP51 in attenuating chemosensitivity of lung cancer cells to cisplatin by regulating DNA damage response. Biotechnol Appl Biochem 70(2):634\u2013644","journal-title":"Biotechnol Appl Biochem"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01121-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-025-01121-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01121-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:02:18Z","timestamp":1766455338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-025-01121-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1007\/s11626-025-01121-3","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read and approved the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}